Treatment of acute tendinitis and bursitis with fentiazac--a double-blind comparison with placebo.
A double-blind comparison of fentiazac and placebo was carried out in 40 adult outpatients with acute nonarticular rheumatism. By random assignment patients received either 100 mg of fentiazac four times a day for one week or an identical-looking placebo in the same dosage. Evaluation was based on improvements in movement-induced pain, pressure-induced pain, and patient's and physician's ratings of therapeutic effect. Fentiazac was significantly better than placebo and produced a similar incidence of side effects, both agents being well tolerated.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000208:Acute Disease; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D002062:Bursitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D052256:Tendinopathy / Q000188:drug therapy*; D013844:Thiazoles
D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010919:Placebos; D013844:Thiazoles; C006124:fentiazac